Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125219142 | 12521914 | 2 | F | 20160323 | 20160630 | 20160701 | 20160708 | EXP | US-BAYER-2016-126394 | BAYER | 52.00 | YR | A | F | Y | 62.13000 | KG | 20160708 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125219142 | 12521914 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | UNK | 204819 | TABLET | ||||||||||
| 125219142 | 12521914 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 4.5 MG, UNK | 204819 | 4.5 | MG | TABLET | |||||||
| 125219142 | 12521914 | 3 | SS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.08 ?G/KG, Q48HR | 0 | .08 | UG/KG | QOD | |||||||
| 125219142 | 12521914 | 4 | SS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.108 ?G/KG, Q48HR | 0 | .108 | UG/KG | QD | |||||||
| 125219142 | 12521914 | 5 | SS | LETAIRIS | AMBRISENTAN | 1 | UNK | 1504767A | 0 | ||||||||||
| 125219142 | 12521914 | 6 | C | ADCIRCA | TADALAFIL | 1 | 0 | ||||||||||||
| 125219142 | 12521914 | 7 | C | TORASEMIDE | TORSEMIDE | 1 | 0 | ||||||||||||
| 125219142 | 12521914 | 8 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 125219142 | 12521914 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125219142 | 12521914 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 125219142 | 12521914 | 11 | C | NORETHINDRONE. | NORETHINDRONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125219142 | 12521914 | 3 | Pulmonary arterial hypertension |
| 125219142 | 12521914 | 4 | Pulmonary arterial hypertension |
| 125219142 | 12521914 | 5 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125219142 | 12521914 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125219142 | 12521914 | Fluid retention | |
| 125219142 | 12521914 | Nocturnal dyspnoea | |
| 125219142 | 12521914 | Oedema | |
| 125219142 | 12521914 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125219142 | 12521914 | 1 | 20160607 | 0 | ||
| 125219142 | 12521914 | 3 | 201503 | 0 | ||
| 125219142 | 12521914 | 5 | 20120815 | 0 | ||
| 125219142 | 12521914 | 11 | 20160527 | 0 |